Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 333

1.

CCL25 chemokine-guided stem cell attraction: an assessment of possible benefits and risks.

Spinnen J, Ringe J, Sittinger M.

Regen Med. 2018 Oct;13(7):833-844. doi: 10.2217/rme-2018-0016. Epub 2018 Oct 4.

PMID:
30284497
2.

Therapeutic Potential of Mesenchymal Cell-Derived miRNA-150-5p-Expressing Exosomes in Rheumatoid Arthritis Mediated by the Modulation of MMP14 and VEGF.

Chen Z, Wang H, Xia Y, Yan F, Lu Y.

J Immunol. 2018 Oct 15;201(8):2472-2482. doi: 10.4049/jimmunol.1800304. Epub 2018 Sep 17.

3.

Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial.

Park EH, Lim HS, Lee S, Roh K, Seo KW, Kang KS, Shin K.

Stem Cells Transl Med. 2018 Sep;7(9):636-642. doi: 10.1002/sctm.18-0031. Epub 2018 Aug 15.

4.

Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients.

Kim KW, Kim HJ, Kim BM, Kwon YR, Kim HR, Kim YJ.

Stem Cell Res Ther. 2018 Aug 9;9(1):208. doi: 10.1186/s13287-018-0948-4.

5.

Exosomes: mediators of bone diseases, protection, and therapeutics potential.

Behera J, Tyagi N.

Oncoscience. 2018 Jun 23;5(5-6):181-195. doi: 10.18632/oncoscience.421. eCollection 2018 May. Review.

6.

Effect of bone marrow mesenchymal stem cells on healing of temporomandibular joints in rats with induced rheumatoid arthritis.

El Qashty RMN, Mohamed NN, Radwan LRS, Ibrahim FMM.

Eur J Oral Sci. 2018 Aug;126(4):272-281. doi: 10.1111/eos.12533. Epub 2018 Jun 27.

PMID:
29952027
7.

Comparative study of methotrexate and human umbilical cord mesenchymal stem cell transplantation in the treatment of rheumatoid arthritis.

Wang YH, Yang ZQ, Zhu SF, Gao Y.

J Biol Regul Homeost Agents. 2018 May-Jun;32(3):599-605.

PMID:
29921387
8.

Intra-articular Injections in the Treatment of Symptoms from Ankle Arthritis: A Systematic Review.

Vannabouathong C, Del Fabbro G, Sales B, Smith C, Li CS, Yardley D, Bhandari M, Petrisor BA.

Foot Ankle Int. 2018 Oct;39(10):1141-1150. doi: 10.1177/1071100718779375. Epub 2018 Jun 18.

PMID:
29909689
9.

Anti-inflammatory and antioxidant effects of mesenchymal and hematopoietic stem cells in a rheumatoid arthritis rat model.

Abdelmawgoud H, Saleh A.

Adv Clin Exp Med. 2018 Jul;27(7):873-880. doi: 10.17219/acem/73720.

10.

Intraperitoneal infusion of mesenchymal stem cell attenuates severity of collagen antibody induced arthritis.

Nam Y, Jung SM, Rim YA, Jung H, Lee K, Park N, Kim J, Jang Y, Park YB, Park SH, Ju JH.

PLoS One. 2018 Jun 7;13(6):e0198740. doi: 10.1371/journal.pone.0198740. eCollection 2018.

11.

Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function.

Alonso-Pérez A, Franco-Trepat E, Guillán-Fresco M, Jorge-Mora A, López V, Pino J, Gualillo O, Gómez R.

Front Physiol. 2018 May 8;9:504. doi: 10.3389/fphys.2018.00504. eCollection 2018. Review.

12.

Cell therapies for refractory rheumatoid arthritis.

Liu R, Zhao P, Tan W, Zhang M.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):911-919. Epub 2018 May 8. Review.

PMID:
29745893
13.

The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells.

Sakata N, Yoshimatsu G, Kodama S.

Int J Mol Sci. 2018 May 7;19(5). pii: E1391. doi: 10.3390/ijms19051391. Review.

14.

Potential of iPSC-Derived Mesenchymal Stromal Cells for Treating Periodontal Disease.

Hynes K, Bright R, Marino V, Ng J, Verma PJ, Gronthos S, Bartold PM.

Stem Cells Int. 2018 Mar 14;2018:2601945. doi: 10.1155/2018/2601945. eCollection 2018.

15.

T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-κB.

Song J, Liu H, Zhu Q, Miao Y, Wang F, Yang F, Cheng W, Xi Y, Niu X, He D, Chen G.

Biomed Res Int. 2018 Feb 19;2018:4901591. doi: 10.1155/2018/4901591. eCollection 2018.

16.

Testing the potency of anti-TNF-α and anti-IL-1β drugs using spheroid cultures of human osteoarthritic chondrocytes and donor-matched chondrogenically differentiated mesenchymal stem cells.

Žigon-Branc S, Barlič A, Knežević M, Jeras M, Vunjak-Novakovic G.

Biotechnol Prog. 2018 Jul;34(4):1045-1058. doi: 10.1002/btpr.2629. Epub 2018 Mar 31.

PMID:
29536646
17.

Comparison of mesenchymal stem cells obtained by suspended culture of synovium from patients with rheumatoid arthritis and osteoarthritis.

Kohno Y, Mizuno M, Ozeki N, Katano H, Otabe K, Koga H, Matsumoto M, Kaneko H, Takazawa Y, Sekiya I.

BMC Musculoskelet Disord. 2018 Mar 9;19(1):78. doi: 10.1186/s12891-018-1998-6.

18.

Transplantation and Alternatives to Treat Autoimmune Diseases.

Shende P, Rodrigues B, Gaud RS.

Adv Exp Med Biol. 2018;1089:59-72. doi: 10.1007/5584_2018_177.

PMID:
29516308
19.

Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis.

Cosenza S, Toupet K, Maumus M, Luz-Crawford P, Blanc-Brude O, Jorgensen C, Noël D.

Theranostics. 2018 Feb 3;8(5):1399-1410. doi: 10.7150/thno.21072. eCollection 2018.

20.

Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial.

Shadmanfar S, Labibzadeh N, Emadedin M, Jaroughi N, Azimian V, Mardpour S, Kakroodi FA, Bolurieh T, Hosseini SE, Chehrazi M, Niknejadi M, Baharvand H, Gharibdoost F, Aghdami N.

Cytotherapy. 2018 Apr;20(4):499-506. doi: 10.1016/j.jcyt.2017.12.009. Epub 2018 Feb 7.

PMID:
29428486

Supplemental Content

Loading ...
Support Center